MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Innate Pharma SA

< Previous 1 2 3 4 5 6 Next >
News headline image
Innate Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
From Innate Pharma SA
Via Business Wire
Tickers IPHA
News headline image
Innate Pharma Announces Conference Call and Webcast
From Innate Pharma SA
Via Business Wire
Tickers IPHA
News headline image
Innate Pharma to Advance Lacutamab Towards Phase 3 Following Partnership With Sobi and Appoints New Chief Medical Officer
From Innate Pharma SA
Via Business Wire
Tickers IPHA
News headline image
Innate Pharma Enters Strategic Partnership With Sobi to License Lacutamab in T-cell Lymphoma
From Innate Pharma SA
Via Business Wire
Tickers IPHA
News headline image
Innate Pharma to Participate in a Bladder Cancer Panel at the BTIG Virtual Biotechnology Conference
From Innate Pharma SA
Via Business Wire
Tickers IPHA
News headline image
Innate Pharma Announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-drug Conjugate (ADC)
From Innate Pharma SA
Via Business Wire
Tickers IPHA
News headline image
Outcome of Innate Pharma’s 2026 Annual General Meeting
From Innate Pharma SA
Via Business Wire
Tickers IPHA
News headline image
Innate Pharma to participate in the Jefferies Global Healthcare Conference
From Innate Pharma SA
Via Business Wire
Tickers IPHA
News headline image
Innate Pharma Reports First Quarter 2026 Business Update and Financial Results
From Innate Pharma SA
Via Business Wire
Tickers IPHA
News headline image
Number of Shares and Voting Rights of Innate Pharma as of April 16, 2026
From Innate Pharma SA
Via Business Wire
Tickers IPHA
News headline image
Innate Pharma Announces Conference Call and Webcast for Q1 2026 Business Update
From Innate Pharma SA
Via Business Wire
Tickers IPHA
News headline image
Innate Pharma to Participate in the D. Boral Capital Global Conference
From Innate Pharma SA
Via Business Wire
Tickers IPHA
News headline image
Innate Pharma to Present MATISSE Phase 2 Interim Results of IPH5201 in Clinical Trials Plenary Session at AACR 2026
From Innate Pharma SA
Via Business Wire
Tickers IPHA
News headline image
Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026
From Innate Pharma SA
Via Business Wire
Tickers IPHA
News headline image
Number of Shares and Voting Rights of Innate Pharma as of April 9, 2026
From Innate Pharma SA
Via Business Wire
Tickers IPHA
News headline image
Innate Pharma to Present at the AACR 2026 Oncology Industry Partnering Event
From Innate Pharma SA
Via Business Wire
Tickers IPHA
News headline image
Innate Pharma to Participate in the Kempen Life Sciences Conference
From Innate Pharma SA
Via Business Wire
Tickers IPHA
News headline image
Innate Pharma Files Its 2025 Universal Registration Document (Document D’enregistrement Universel) and 2025 Form 20-f Annual Report
From Innate Pharma SA
Via Business Wire
Tickers IPHA
News headline image
Innate Pharma Reports Full Year 2025 Financial Results and Business Update
From Innate Pharma SA
Via Business Wire
Tickers IPHA
News headline image
Innate Pharma Announces Conference Call and Webcast for Full Year 2025 Financial Results
From Innate Pharma SA
Via Business Wire
Tickers IPHA
News headline image
Number of Shares and Voting Rights of Innate Pharma as of February 19, 2026
From Innate Pharma SA
Via Business Wire
Tickers IPHA
News headline image
Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference
From Innate Pharma SA
Via Business Wire
Tickers IPHA
News headline image
Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025
From Innate Pharma SA
Via Business Wire
Tickers IPHA
News headline image
Innate Pharma Releases Its 2026 Financial Calendar
From Innate Pharma SA
Via Business Wire
Tickers IPHA
News headline image
Number of Shares and Voting Rights of Innate Pharma as of November 27, 2025
From Innate Pharma SA
Via Business Wire
Tickers IPHA
News headline image
Innate Pharma to Present at Jefferies Global Healthcare Conference
From Innate Pharma SA
Via Business Wire
Tickers IPHA
News headline image
Innate Pharma Reports Third Quarter 2025 Business Update and Financial Results
From Innate Pharma SA
Via Business Wire
Tickers IPHA
News headline image
Innate Pharma Announces FDA Clearance to Proceed With TELLOMAK 3, a Confirmatory Phase 3 Trial of Lacutamab in CTCL
From Innate Pharma SA
Via Business Wire
Tickers IPHA
News headline image
Innate Pharma Announces Conference Call and Webcast for Third Quarter 2025 Results and Business Updates
From Innate Pharma SA
Via Business Wire
Tickers IPHA
News headline image
Innate Pharma to Host Analyst and Investor Event on Lacutamab on October 28, 2025
From Innate Pharma SA
Via Business Wire
Tickers IPHA
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story